|
Match
|
Document |
Document Title |
|
|
7618951 |
Use of prebiotics, preferably glucooligosaccharide, for the prevention of the onset of type II diabetes
The invention relates to the use of prebiotics for the preparation of food or pharmaceutical compositions which are intended for the treatment and/or prevention of hyperglycaemic syndromes and, in...
|
|
|
7612029 |
Controlled release using gels in a melamine foam
A substrate comprising a nonwoven layer containing an ionically crosslinked polymer can be used to control the release of active ingredients. The substrate can be a melamine foam and contain a...
|
|
|
7608708 |
Monocotyledon plant cells and plants which synthesize modified starch
The present invention relates to monocotyledon plant cells and plants which are genetically modified, wherein the genetic modification consists of the introduction of an extraneous nucleic acid...
|
|
|
7608436 |
Process for producing saccharide oligomers
A process for preparing saccharide oligomers uses an aqueous feed composition that comprises at least one monosaccharide or linear saccharide oligomer, and has a solids concentration of at least...
|
|
|
7605232 |
Hydrogels for protein concentration
A method of concentrating proteins from whole blood comprising exposing whole blood to covalently crosslinked hydrogel to remove water from the blood into the hydrogel to thereby concentrate the...
|
|
|
7601705 |
Polymer controlled induced viscosity fiber system and uses thereof
The present invention relates generally to a method of blunting the postprandial glycemic response in a human by feeding an induced viscosity fiber system. The invention also relates to an induced...
|
|
|
7601704 |
Process for synthesizing oil and surfactant-free hyaluronic acid nanoparticles and microparticles
A method for synthesizing uniformly sized hyaluronic acid (“HA”) particles that are substantially free from oil and surfactant contaminants. The method comprises crosslinking HA chains with...
|
|
|
7601364 |
Carbohydrate mixtures
A carbohydrate mixture for dietetic foods and pharmaceuticals containing several carbohydrates is provided. The carbohydrate mixture comprises two different, substantially soluble carbohydrate...
|
|
|
7595392 |
Biodegradable oxidized cellulose esters
The present invention relates to the preparation of a series of oxidized cellulose esters suitable for use as a drug carrier in the development of biodegradable controlled and/or sustained release...
|
|
|
7595307 |
Polysaccharide derivatives and uses in induction of an immune response
The present invention generally provides compositions comprising a polysaccharide derivative, and methods of their preparation and use for the prevention or treatment of diseases caused by ...
|
|
|
7592327 |
Asthma/allergy therapy that targets T-lymphocytes and/or eosinophils
A pharmaceutical composition for the treatment and/or prophylaxis of diseases caused by type I hypersensitivity reactions consisting essentially of Glicophosphopeptical, or pure Nigella Sativa ...
|
|
|
7589080 |
β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
Methods of reducing the risk of transmission of a sexually transmitted pathogen by contacting the pathogen or cells susceptible to infection by the pathogen with a β-cyclodextrin are provided....
|
|
|
7589051 |
Cationic, oxidized polysaccharides in conditioning applications
A cationic, oxidized polysaccharide or derivative thereof that has a mean average molecular weight (Mw) having a lower limit of 50,000 and an upper limit of 1,000,000 and an aldehyde functionality...
|
|
|
7582620 |
Use of mannan from saccharomyces cerevisiae for the treatment of asthma
The present invention provides methods of using mannose receptor blocker to treat airway disease such as asthma. The present invention also provides methods for reducing smooth muscle mass in an...
|
|
|
7582311 |
Injection vehicle for polymer-based formulations
The invention provides injection vehicles suitable for administering particulate suspensions, such as polymer-based formulations, as well as associated pharmaceutical formulations, articles of...
|
|
|
7579017 |
Physical mode of action pesticide
A physical mode of action pesticide for application on plants and in soils, and methods of manufacture and application, comprising an active ingredient in the form of a polymer in a concentration...
|
|
|
7576071 |
Antithrombotic compound
The present invention relates compounds of the formula A
oligosaccharide-spacer-GpIIb/IIIa antagonist (A).
|
|
|
7576070 |
Method for producing pectin hydrolysis products
The present invention relates to methods for the production of pectin hydrolysis products, the pectin hydrolysis products produced in this manner, as well as their use.
|
|
|
7575755 |
Immunogenic compositions and uses thereof
The present invention relates generally to a method of eliciting or otherwise inducing an effective immune response to a micro-organism and compositions for use therein. More particularly, the...
|
|
|
7569557 |
Compositions of estrogen-cyclodextrin complexes
Pharmaceutical compositions comprising low doses of sensitive complexes between an estrogen and a cyclodextrin are provided with improved stability. In specific embodiments the composition...
|
|
|
7566704 |
Very high molecular weight β-glucans
The invention pertains to compositions and therapeutic and prophylatic methods for treating/preventing infections in an animal or human by administering a soluble β-glucan composition comprising...
|
|
|
7560443 |
Mixtures of fructose, sucrose and lactose as a low-calorie bulk sweetener with reduced glycemic index
Mixtures of fructose and lactose are useful for reducing caloric intake and glycemic index for individuals who are overweight, glucose-impaired, diabetic, or who just consume too large a fraction...
|
|
|
7553824 |
Kit for determining polysaccharide-binding activity of mononuclear cells present in peripheral blood
A kit for the determination of the ability of a peripheral blood mononuclear cell to bind to a polysaccharide herein provided comprises a detection reagent comprising a fluorescence-labeled...
|
|
|
7553482 |
Use of a phosphate adsorbent to combat vascular diseases
The invention relates to the use of an adsorption material which has been modified with polynuclear metal oxide hydroxides for influencing the calcium level and, in particular, for treating or/and...
|
|
|
7553479 |
Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof
Compositions, methods of making the compositions, and methods of using the compositions are provided for an enhanced magnetic resonance imaging agent and a hematinic agent, the agents comprising...
|
|
|
7544671 |
Stabilized hyaluronan preparations and related methods
Stabilized hyaluronan preparations wherein hyaluronan is combined with a polyglycol, such as polyethylene glycol. Stabilized hyaluronan preparations of this invention may maintain their viscosity...
|
|
|
7541445 |
Synthetic heparin pentasaccharides
Preparation of synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides for use in the preparation of synthetic heparinoids.
|
|
|
7538096 |
Treatment and prevention of abnormal cellular proliferation
This invention provides a method for inhibiting or preventing the abnormal growth of cells, including transformed cells, by administering an effective amount of O-acylated heparin derivative....
|
|
|
7524514 |
Biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan
The present invention relates to a three dimensional, malleable cell culture composition and method of forming the same comprising hyaluronic acid, chitosan and a polyelectrolytic complex of...
|
|
|
7521434 |
Cross-linked gels of hyaluronic acid with hydrophobic polymers and processes for making them
The present invention provides for compositions of hyaluronic acid cross-linked with at least one other hydrophobic polymer to form a copolymer gel. The preferred composition is a formulation...
|
|
|
7521433 |
Gene carriers with the use of polysaccharide and process for producing the same
Disclosed are gene carriers utilizing β-1,3-glucan and methods of preparing the same. The β-1,3-glucan has at least one 1,6-glucopyranoside branch and is chemically modified through periodate...
|
|
|
7517980 |
Glycomimetric inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from Pseudomonas
Compositions and methods are provided related to Pseudomonas bacteria. The compositions and methods may be used for diagnosis and therapy of medical conditions involving infection with ...
|
|
|
7514097 |
Use of soluble cellulose derivative having been made hardly soluble in water and process for producing the same
(1) A tissue-covering medical material which comprises a soluble cellulose derivative having been made hardly soluble in water, which is used with a purpose of being embedded in the body or applied...
|
|
|
7511095 |
Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith
The invention provides reagents and methods for conjugating a polymer specifically to the α-amine of a polypeptide. The invention provides monofunctional, bifunctional, and multifunctional PEGs...
|
|
|
7511026 |
Therapeutic agent for nerve damage
The present invention provides a therapeutic agent for nerve damages such as those caused by spinal cord injury or nerve trauma, which includes, as an active ingredient, a low-molecular-weight...
|
|
|
7507723 |
Hyaluronic acid oligosaccharide fractions and drugs containing the same
Hyaluronic acid oligosaccharides having a size selected from sizes of 4 to 60 saccharides, fractions containing the hyaluronic acid oligosaccharides and having particular physicochemical...
|
|
|
7504387 |
Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
The invention provides compositions and methods useful for the treatment and/or prevention of interstitial cystitis and/or a related urinary tract condition in man or in animals. Specifically,...
|
|
|
7504386 |
Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives
New biomaterials essentially constituted by esterified derivatives of hyaluronic acid or by cross-linked derivatives of hyaluronic acid for use in the surgical sector, particularly for use in the...
|
|
|
7504384 |
Use of lipid conjugates in the treatment of infection
This invention provides compounds and methods of use thereof in suppressing, inhibiting, preventing, or treating a pathogenic effect on a cell, including, inter alia, infection with intracellular...
|
|
|
7501402 |
Fucose containing proteoglycan or acidic glycan and their pharmaceutical use
A class of proteoglycans containing fucosylated acidic glycans, e.g., as produced by marine sponges and sea urchin embryos, have been found to stimulate selective proliferation of mammalian natural...
|
|
|
7498317 |
Antibacterial agents and process for producing the same
An antibacterial agent showing a high affinity for Helicobactor pyroli and having an antibacterial effect specific to H. Pyroli. The agent has a chemical structure wherein an antibacterial...
|
|
|
7495030 |
(5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
(5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid, salts thereof, and compositions containing the same for the delivery of active agents are provided. Methods of administration, treatment of disease...
|
|
|
7494674 |
Nutraceutical with tart cherries and method of treatment therewith
The present disclosure provides a nutraceutical for the use of a vacuolar flavonoid pigment from a natural source such as tart cherries as an additional compound as part of a mixture including at...
|
|
|
7491709 |
Treatment with hyaluronic acid
The present invention relates, generally, to methods of providing long-term minimization of wrinkles or folds in the skin by injecting a bolus of hyaluronic acid deep into the skin. The methods of...
|
|
|
7491708 |
Modified pectin
A modified pectin consists essentially of neutral sugar sequences with a low degree of branching capable of preventing tumor cell migration and cell to cell and cell to substratum adhesion.
|
|
|
7485719 |
Crosslinkable polysaccharide derivative, process for producing the same, crosslinkable polysaccharide composition, and medical treatment material
A crosslinkable polysaccharide derivative which has in the side chain of polysaccharide at least one active ester group reactive with an active hydrogen-containing group and which forms a...
|
|
|
7485718 |
Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines
A process for the synthesis of beta linked low molecular weight polymers of galactosamine and glucosamine has been developed. Through the use of high amounts of activating agents, efficient...
|
|
|
7482026 |
Compositions and methods directed towards sore muscles and joints
Chemical formulations and methods for reducing muscle and joint soreness are disclosed. A representative chemical formulation includes compounds such as a selenium-compound, chondroitin sulfate,...
|
|
|
7473429 |
Method for treatment of laminitis in animals
The present invention generally relates to methods for treating the sequela of laminitis in hoofed animals. Benefits are obtained by administering to the animals to be treated injections of...
|
|
|
7465716 |
Targeted drug delivery with a hyaluronan ligand
The invention is a drug delivery system of a delivery vehicle having a low molecular weight hyaluronan ligand with an affinity for CD44 receptors. Preferably, the delivery vehicle is a liposome but...
|